Scientists have introduced an ultrafast MRI method that can determine the direction of brain signal flow, potentially deepening understanding of conditions like autism and Alzheimer’s. Separately, ...
Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...
Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics designed to restore synapses to improve the lives of patients, will present this ...
Up to 30% of people with migraines experience an aura phase, a sensation characterized by visual or sensory disturbances such ...
Phase I/II clinical trial interim results, out to 168 days, from the two RV-001 dosing cohorts with advanced Retinitis ...
Key findings from the DME AWARE initiative highlight the importance of non-invasive treatment options for early intervention ...
Ocular infections and related inflammatory disorders are important causes of visual morbidity worldwide and may arise from viral, bacterial, fungal, and ...
Why do humans fear the dark? How can the science of evolutionary biology explain this primitive instinct? Fear of the dark, ...
Your risk of cognitive decline and dementia rises with small amounts of ultraprocessed foods, even when you are trying to eat ...
You might have heard people talking about their nervous system being "overloaded" or "dysregulated" when they're going ...
Gains in best corrected visual acuity (BCVA) of +9 letters at 36 months among patients with extensive coverage of OpRegen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results